Johnson, R.L.; Ganesan, S.; Thangavelu, A.; Theophilou, G.; de Jong, D.; Hutson, R.; Nugent, D.; Broadhead, T.; Laios, A.; Cummings, M.;
et al. Immune Checkpoint Inhibitors Targeting the PD-1/PD-L1 Pathway in Advanced, Recurrent Endometrial Cancer: A Scoping Review with SWOT Analysis. Cancers 2023, 15, 4632.
https://doi.org/10.3390/cancers15184632
AMA Style
Johnson RL, Ganesan S, Thangavelu A, Theophilou G, de Jong D, Hutson R, Nugent D, Broadhead T, Laios A, Cummings M,
et al. Immune Checkpoint Inhibitors Targeting the PD-1/PD-L1 Pathway in Advanced, Recurrent Endometrial Cancer: A Scoping Review with SWOT Analysis. Cancers. 2023; 15(18):4632.
https://doi.org/10.3390/cancers15184632
Chicago/Turabian Style
Johnson, Racheal Louise, Subhasheenee Ganesan, Amudha Thangavelu, Georgios Theophilou, Diederick de Jong, Richard Hutson, David Nugent, Timothy Broadhead, Alexandros Laios, Michele Cummings,
and et al. 2023. "Immune Checkpoint Inhibitors Targeting the PD-1/PD-L1 Pathway in Advanced, Recurrent Endometrial Cancer: A Scoping Review with SWOT Analysis" Cancers 15, no. 18: 4632.
https://doi.org/10.3390/cancers15184632
APA Style
Johnson, R. L., Ganesan, S., Thangavelu, A., Theophilou, G., de Jong, D., Hutson, R., Nugent, D., Broadhead, T., Laios, A., Cummings, M., & Orsi, N. M.
(2023). Immune Checkpoint Inhibitors Targeting the PD-1/PD-L1 Pathway in Advanced, Recurrent Endometrial Cancer: A Scoping Review with SWOT Analysis. Cancers, 15(18), 4632.
https://doi.org/10.3390/cancers15184632
